News about investment, healthcare and the life-sciences industry
News about investment, healthcare and the life-sciences industry
2022 Recap: A Year For The Books of Infusion 51a
2022 was -no news- a year of economic turmoil, with the global rise in inflation dwarfing all sectors and uncertainty pervading the near-term outlook. The
Insights from the Pereiras’ after cancer struck their home twice: takeaways every patient needs to read
When a family member develops cancer, it affects the group as a whole: the trauma can either isolate individuals, who are dealing with their pain
From Nurse to Patient: the Journey of an Australian Mother Overcoming GBM
Maija Kumpulainen is the living proof of how you must not be blinded and discouraged by pessimist statistics. Discover the inspiring story of this Australian mother who beat the deadliest form of brain cancer, glioblastoma multiforme.
Getting a Glioblastoma Diagnosis at the Start of the Coronavirus Crisis: The Story of Carol Burkhart
Carol Burkhart was diagnosed with Glioblastoma multiforme (grade IV), the deadliest form of brain cancer, during the early days of the coronavirus outbreak. For us, March 2020 represents the beginning of the pandemic; for her, the start of her cancer journey in the midst of an unprecedented world crisis.
Thinking of expanding to the Middle East? Might be worth considering -We did it!
A Question Answered by Infusion 51a’s General Partner, Jeff Stephens As a human, my passion is to help people. As a businessman, my passion is
2022 World Health Day: Why we need climate action at the center of human health?
As we left March and the second anniversary of the pandemic behind, April appears as an ideal opportunity to reflect on global health and how